24 June 2020>: Clinical Research
Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma
Jingyuan Li 1AE , Xingyuan Liu 23CF , Zan Cui 1B , Guanying Han 1DG*DOI: 10.12659/MSM.922070
Med Sci Monit 2020; 26:e922070
Figure 4 DEGs were validated in LUAD and normal lung tissue. The gene expression of (A) PECAM1, (B) CDK1, (C) MKI67, (D) SPP1, (E) TOP2A, (F) CHEK1, (G) CCNB1, (H) RRM2 in 483 LUAD patients and 347 normal tissues was evaluated by GEPIA. The relative mRNA expression levels of (I) PECAM1, (J) CDK1, (K) MKI67, (L) SPP1, (M) TOP2A, (N) CHEK1, (O) CCNB1, and (P) RRM2 between 28 LUAD patients and 8 normal lung tissues were determined by RT-qPCR. All data are shown as the mean±SD, ### P<0.001 versus the normal group. DEGs – differentially expressed genes; LUAD – lung adenocarcinoma; GEPIA – Gene Expression Profiling Interactive Analysis; mRNA – messenger RNA; RT-qPCR – real-time quantitative polymerase chain reaction; SD – standard deviation.